Vital Farms, Inc. filings document operating results, governance matters and material events for a public ethical food company built around pasture-raised eggs and related food products. Form 8-K reports furnish earnings releases, Regulation FD updates, product portfolio actions and exit or disposal activity tied to butter offerings.
Proxy and stockholder-meeting disclosures cover director elections, board structure, executive compensation advisory votes, governance policies and shareholder voting results. Other current reports document board appointments, board leadership transitions, committee service, indemnification arrangements and related corporate-governance matters for the Nasdaq-listed Delaware public benefit corporation.
Vital Farms, Inc. director Denny Marie Post reported an open-market purchase of Common Stock. On May 13, 2026, she bought 3,000 shares at $8.23 per share. Following this transaction, her direct ownership increased to 19,312 shares of Vital Farms common stock.
Vital Farms, Inc. Schedule 13G shows Van Berkom & Associates Inc. reports beneficial ownership of 2,437,508 common shares of Vital Farms, representing 5.44% of the class as of 03/31/2026. The filing lists sole voting and sole dispositive power over the reported shares.
Vital Farms, Inc. reported first quarter 2026 results showing solid sales growth but sharply weaker profitability and a strategic shift in its product portfolio. Net revenue rose 15.4% to $187.2 million, driven by higher volumes, but gross margin fell to 28.3% from 38.5% as oversupply pushed more eggs into lower-priced breaker and wholesale channels.
The company swung to a net loss of $1.5 million, or $0.03 per diluted share, versus net income of $16.9 million a year earlier. Adjusted EBITDA dropped to $5.0 million from $27.5 million. Management decided to wind down the butter business by the end of fiscal 2026 to focus on core egg categories, which it expects to be margin accretive after exit.
Vital Farms ended the quarter with $51.4 million in cash, cash equivalents and marketable securities and no debt, after investing heavily in its Vital Crossroads facility and accelerator farms and repurchasing 1.0 million shares for $20.0 million. For fiscal 2026, it now expects net revenue of $775–$800 million, at least 5% growth over 2025, Adjusted EBITDA of $0–$10 million, and reduced capital expenditures of $70–$75 million.
Vital Farms, Inc. provides its 2026 proxy for a virtual Annual Meeting on June 10, 2026 at 9:00 a.m. Central Time. Stockholders will vote on electing two Class III directors, ratifying KPMG as auditor, and approving an advisory say‑on‑pay resolution.
The company describes a classified eight‑member board, a combined Chair and CEO role with a Lead Independent Director, and policies such as a majority‑vote resignation guideline and non‑employee director tenure limits. It highlights active investor outreach and independence of all directors except the CEO.
Vital Farms underscores its status as a Delaware public benefit corporation and Certified B Corporation, along with Impact goals. By 2025 it achieved 99% completion of ethics training, reduced operational greenhouse gas intensity by 18.3% from 2022, and engaged 59% of farmers on regenerative agriculture practices.
Wasatch Advisors filed an Amendment No. 1 to Schedule 13G/A reporting beneficial ownership of 1,933,119 shares of Vital Farms Inc. The filing states this equals 4.3% of the class and shows sole voting power of 1,371,807 shares and sole dispositive power of 1,933,119 shares. The filing lists Vital Farms Inc CUSIP 92847W103 and cites Delaware as the filer’s citizenship. The Schedule indicates the holder reports ownership under the “5 percent or less of a class” category. Signature is provided by Mike Yeates, CEO.
Wasatch Advisors filed an Amendment No. 1 to Schedule 13G/A reporting beneficial ownership of 1,933,119 shares of Vital Farms Inc. The filing states this equals 4.3% of the class and shows sole voting power of 1,371,807 shares and sole dispositive power of 1,933,119 shares. The filing lists Vital Farms Inc CUSIP 92847W103 and cites Delaware as the filer’s citizenship. The Schedule indicates the holder reports ownership under the “5 percent or less of a class” category. Signature is provided by Mike Yeates, CEO.
Vital Farms Inc (Common Stock) — The Vanguard Group filed an amendment to its Schedule 13G/A reporting a reallocation of beneficial‑ownership reporting following an internal realignment. The filing states that, following the realignment referenced to January 12, 2026, certain Vanguard subsidiaries will report separately and The Vanguard Group reports 0 shares beneficially owned and 0% of the class. The filing lists Vanguard's business address as 100 Vanguard Blvd., Malvern, PA and Vital Farms' principal executive office as 3601 South Congress Avenue, Suite C100, Austin, TX, 78704. The amendment is signed by Ashley Grim, Head of Global Fund Administration, dated 03/27/2026.
Vital Farms, Inc. Chief Financial Officer Thilo Wrede reported a routine tax-related share disposition. On March 18, 2026, 3,192 shares of common stock were withheld by the company at $15.70 per share to satisfy withholding tax obligations, rather than being sold in the open market. After this transaction, Wrede directly held 75,477 shares of Vital Farms common stock.
Vital Farms, Inc. executive Kathryn McKeon, CMO and GM, Butter, reported routine tax-related share withholdings. On two March transactions, a total of 2,611 shares of common stock were withheld by the company to satisfy tax obligations, rather than sold on the open market. After these dispositions, she directly holds 49,671 shares of Vital Farms common stock.